Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

28 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Feasibility of flowcytometric quantitation of immune effector cell subsets in the sentinel lymph node of the breast after cryopreservation.
van Pul KM, Vuylsteke RJ, Bril H, Stockmann HB, de Gruijl TD. van Pul KM, et al. Among authors: vuylsteke rj. J Immunol Methods. 2012 Jan 31;375(1-2):189-95. doi: 10.1016/j.jim.2011.10.011. Epub 2011 Oct 26. J Immunol Methods. 2012. PMID: 22062586
Sentinel lymph node investigation in melanoma: detailed analysis of the yield from step sectioning and immunohistochemistry.
Gietema HA, Vuylsteke RJ, de Jonge IA, van Leeuwen PA, Molenkamp BG, van der Sijp JR, Meijer S, van Diest PJ. Gietema HA, et al. Among authors: vuylsteke rj. J Clin Pathol. 2004 Jun;57(6):618-20. doi: 10.1136/jcp.2003.011742. J Clin Pathol. 2004. PMID: 15166267 Free PMC article.
Clinical outcome of stage I/II melanoma patients after selective sentinel lymph node dissection: long-term follow-up results.
Vuylsteke RJ, van Leeuwen PA, Statius Muller MG, Gietema HA, Kragt DR, Meijer S. Vuylsteke RJ, et al. J Clin Oncol. 2003 Mar 15;21(6):1057-65. doi: 10.1200/JCO.2003.07.170. J Clin Oncol. 2003. PMID: 12637471
The sentinel lymph node status is an important factor for predicting clinical outcome in patients with Stage I or II cutaneous melanoma.
Statius Muller MG, van Leeuwen PA, de Lange-De Klerk ES, van Diest PJ, Pijpers R, Ferwerda CC, Vuylsteke RJ, Meijer S. Statius Muller MG, et al. Among authors: vuylsteke rj. Cancer. 2001 Jun 15;91(12):2401-8. Cancer. 2001. PMID: 11413531
No indication for performing sentinel node biopsy in melanoma patients with a Breslow thickness of less than 0.9 mm.
Statius Muller MG, van Leeuwen PA, van Diest PJ, Vuylsteke RJ, Pijpers R, Meijer S. Statius Muller MG, et al. Among authors: vuylsteke rj. Melanoma Res. 2001 Jun;11(3):303-7. doi: 10.1097/00008390-200106000-00013. Melanoma Res. 2001. PMID: 11468520
Selectively hampered activation of lymph node-resident dendritic cells precedes profound T cell suppression and metastatic spread in the breast cancer sentinel lymph node.
van Pul KM, Vuylsteke RJCLM, van de Ven R, Te Velde EA, Rutgers EJT, van den Tol PM, Stockmann HBAC, de Gruijl TD. van Pul KM, et al. Among authors: vuylsteke rjclm. J Immunother Cancer. 2019 May 22;7(1):133. doi: 10.1186/s40425-019-0605-1. J Immunother Cancer. 2019. PMID: 31118093 Free PMC article.
Tumor-specific CD8+ T cell reactivity in the sentinel lymph node of GM-CSF-treated stage I melanoma patients is associated with high myeloid dendritic cell content.
Vuylsteke RJ, Molenkamp BG, van Leeuwen PA, Meijer S, Wijnands PG, Haanen JB, Scheper RJ, de Gruijl TD. Vuylsteke RJ, et al. Clin Cancer Res. 2006 May 1;12(9):2826-33. doi: 10.1158/1078-0432.CCR-05-2431. Clin Cancer Res. 2006. PMID: 16675577 Clinical Trial.
Matched skin and sentinel lymph node samples of melanoma patients reveal exclusive migration of mature dendritic cells.
Molenkamp BG, Vuylsteke RJ, van Leeuwen PA, Meijer S, Vos W, Wijnands PG, Scheper RJ, de Gruijl TD. Molenkamp BG, et al. Among authors: vuylsteke rj. Am J Pathol. 2005 Nov;167(5):1301-7. doi: 10.1016/S0002-9440(10)61217-5. Am J Pathol. 2005. PMID: 16251414 Free PMC article.
Sentinel lymph node tumor load: an independent predictor of additional lymph node involvement and survival in melanoma.
Vuylsteke RJ, Borgstein PJ, van Leeuwen PA, Gietema HA, Molenkamp BG, Statius Muller MG, van Diest PJ, van der Sijp JR, Meijer S. Vuylsteke RJ, et al. Ann Surg Oncol. 2005 Jun;12(6):440-8. doi: 10.1245/ASO.2005.06.013. Epub 2005 Apr 19. Ann Surg Oncol. 2005. PMID: 15864481
Local administration of granulocyte/macrophage colony-stimulating factor increases the number and activation state of dendritic cells in the sentinel lymph node of early-stage melanoma.
Vuylsteke RJ, Molenkamp BG, Gietema HA, van Leeuwen PA, Wijnands PG, Vos W, van Diest PJ, Scheper RJ, Meijer S, de Gruijl TD. Vuylsteke RJ, et al. Cancer Res. 2004 Nov 15;64(22):8456-60. doi: 10.1158/0008-5472.CAN-03-3251. Cancer Res. 2004. PMID: 15548718 Clinical Trial.
28 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback